Article (Scientific journals)
Oxytocin in survivors of childhood-onset craniopharyngioma
Daubenbüchel, Anna; Hoffmann, Anika; Eveslage, Maria et al.
2016In Endocrine
Peer Reviewed verified by ORBi
 

Files


Full Text
OT craniopharyngioma.pdf
Publisher postprint (1.02 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Craniopharyngioma; Hypothalamus; Oxytocin; Behavior; Obesity
Abstract :
[en] Quality of survival of childhood-onset cranio- pharyngioma patients is frequently impaired by hypotha- lamic involvement or surgical lesions sequelae such as obesity and neuropsychological deficits. Oxytocin, a pep- tide hormone produced in the hypothalamus and secreted by posterior pituitary gland, plays a major role in regula- tion of behavior and body composition. In a cross- sectional study, oxytocin saliva concentrations were ana- lyzed in 34 long-term craniopharyngioma survivors with and without hypothalamic involvement or treatment- related damage, recruited in the German Childhood Cra- niopharyngioma Registry, and in 73 healthy controls, attending the Craniopharyngioma Support Group Meeting 2014. Oxytocin was measured in saliva of craniophar- yngioma patients and controls before and after standar- dized breakfast and associations with gender, body mass index, hypothalamic involvement, diabetes insipidus, and irradiation were analyzed. Patients with preoperative hypothalamic involvement showed similar oxytocin levels compared to patients without hypothalamic involvement and controls. However, patients with surgical hypotha- lamic lesions grade 1 (anterior hypothalamic area) pre- sented with lower levels (p = 0.017) of oxytocin under fasting condition compared to patients with surgical lesion of posterior hypothalamic areas (grade 2) and patients without hypothalamic lesions (grade 0). Craniophar- yngioma patients’ changes in oxytocin levels before and after breakfast correlated (p = 0.02) with their body mass index. Craniopharyngioma patients continue to secrete oxytocin, especially when anterior hypothalamic areas are not involved or damaged, but oxytocin shows less varia- tion due to nutrition. Oxytocin supplementation should be explored as a therapeutic option in craniopharyngioma patients with hypothalamic obesity and/or behavioral pathologies due to lesions of specific anterior hypotha- lamic areas. Clinical trial number: KRANIOPHAR- YNGEOM 2000/2007(NCT00258453; NCT01272622).
Disciplines :
Neurology
Endocrinology, metabolism & nutrition
Author, co-author :
Daubenbüchel, Anna;  Klinikum Oldenburg AöR, Germany > Pediatrics
Hoffmann, Anika;  Klinikum Oldenburg AöR, Germany > Pediatrics
Eveslage, Maria;  University of Münster, Germany > Institute of Bioatatistics and Clinical Research
Özyurt, Jale;  University of Oldenburg, Germany > Biological Psychology
Lohle, Kristin;  Klinikum Oldenburg AöR, Germany > Pediatrics
Reichel, Julia;  Klinikum Oldenburg AöR, Germany > Pediatrics
Thiel, Christiane M.;  University of Oldenburg, Germany > Research Center Neurosensory Science
Martens, Henri ;  Université de Liège > Centre d'immunologie
Geenen, Vincent ;  Université de Liège > Centre d'immunologie
Müller, Hermann L.;  Klinikum Oldenburg AöR, Germany > Pediatrics
Language :
English
Title :
Oxytocin in survivors of childhood-onset craniopharyngioma
Publication date :
September 2016
Journal title :
Endocrine
ISSN :
1355-008X
eISSN :
1559-0100
Publisher :
Humana Press, Totowa, United States - New Jersey
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
German Childhood Cancer Foundation
Available on ORBi :
since 07 September 2016

Statistics


Number of views
274 (6 by ULiège)
Number of downloads
864 (2 by ULiège)

Scopus citations®
 
47
Scopus citations®
without self-citations
30
OpenCitations
 
42

Bibliography


Similar publications



Contact ORBi